Judit Dobos

1.3k citations

33 papers · 989 indexed · h-index 18

Impact in

Biological Psychiatry top 10%
Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis

Papers in ⓘ

Molecular Biology 18
- Melanoma and MAPK Pathways 6
- Angiogenesis and VEGF in Cancer 5
- PI3K/AKT/mTOR signaling in cancer 3
Oncology 15
- HER2/EGFR in Cancer Research 4
- Cancer-related Molecular Pathways 3

Co-authors: József Tı́már (20 shared papers)István Kenessey (15 shared papers)József Tóvári (17 shared papers)Balázs Döme (10 shared papers)Andrea Ladányi (7 shared papers)Sándor Paku (4 shared papers)Gyula Ostoros (4 shared papers)Erzsébet Rásó (7 shared papers)
Journals: Pathology & Oncology Research (4 papers)Cancer Research (3 papers)European Journal of Medicinal Chemistry (2 papers)Journal of Affective Disorders (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
Partner nations: Hungary Austria United States

In The Last Decade

Judit Dobos

33 papers receiving 978 citations

Peers

Countries citing papers authored by Judit Dobos

Since Specialization

Citations

This map shows the geographic impact of Judit Dobos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judit Dobos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judit Dobos more than expected).

Fields of papers citing papers by Judit Dobos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judit Dobos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judit Dobos. The network helps show where Judit Dobos may publish in the future.

Co-authors

The 25 scholars most cited alongside Judit Dobos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Judit Dobos Line = papers co-authored together Judit Dobos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Identification and Clinical Significance of Circulating Endothelial Progenitor Cells in Human Non–Small Cell Lung Cancer Cancer Research ·Balázs Döme, József Tı́már, Judit Dobos, Lívia S. Mészáros, Erzsébet Rásó, Sándor Paku, István Kenessey, Gyula Ostoros, Melinda Magyar, Andrea Ladányi, Krisztina Bogos, József Tóvári	2006	143
2	Prognostic impact of B-cell density in cutaneous melanoma Cancer Immunology Immunotherapy ·Andrea Ladányi, Judit Kiss, Anita Mohos, Beáta Somlai, Gabriella Liszkay, Katalin Gilde, Zsuzsanna Fejôs, István Gaudi, Judit Dobos, József Tı́már	2011	138
3	Apelin Expression in Human Non-small Cell Lung Cancer: Role in Angiogenesis and Prognosis Journal of Thoracic Oncology ·Judit Berta, István Kenessey, Judit Dobos, József Tóvári, Walter Klepetko, Hendrik Jan Ankersmit, Balázs Hegedűs, F Rényi-Vámos, János Varga, Zsolt Lőrincz, Sándor Paku, Gyula Ostoros, Anita Rózsás, József Tı́már, Balázs Döme	2010	106
4	Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul Molecular Psychiatry ·Péter Döme, Z Teleki, Z. Ríhmer, Luisa Peter, Judit Dobos, István Kenessey, József Tóvári, József Tı́már, Sándor Paku, Gábor L. Kovaćs, Balázs Döme	2008	81
5	Circulating bone marrow‐derived endothelial progenitor cells: Characterization, mobilization, and therapeutic considerations in malignant disease Cytometry Part A ·Balázs Döme, Judit Dobos, József Tóvári, Sándor Paku, Gábor L. Kovaćs, Gyula Ostoros, József Tı́már	2007	51
6	In vitro and in vivo antitumor effect of 2‐methoxyestradiol on human melanoma International Journal of Cancer ·Judit Dobos, József Tı́már, József Bocsi, Zsuzsanna Burián, Katalin Nagy, Gábor Barna, István Peták, Andrea Ladányi	2004	47
7	Molecular Characterization of 103 Ovarian Serous and Mucinous Tumors Pathology & Oncology Research ·Ildikó Vereczkey, Orsolya Serester, Judit Dobos, Mónika Gallai, Orsolya Szakács, Zoltán Szentirmay, Erika Tóth	2010	45
8	High VEGFR-3–positive Circulating Lymphatic/Vascular Endothelial Progenitor Cell Level Is Associated with Poor Prognosis in Human Small Cell Lung Cancer Clinical Cancer Research ·Krisztina Bogos, F Rényi-Vámos, Judit Dobos, István Kenessey, József Tóvári, József Tı́már, János Strausz, Gyula Ostoros, Walter Klepetko, Hendrik Jan Ankersmit, György Láng, Mir Alireza Hoda, Patrick Nierlich, Balázs Döme	2009	38
9	Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: Results of a preliminary study Journal of Affective Disorders ·Zsuzsa Halmai, Péter Döme, Judit Dobos, Xénia Gonda, Anna Székely, Mária Sasvári‐Székely, Gábor Faludi, Judit Lazáry	2012	34
10	Design and synthesis of new imidazo[1,2- a ]pyridine and imidazo[1,2- a ]pyrazine derivatives with antiproliferative activity against melanoma cells European Journal of Medicinal Chemistry ·Rita Garamvölgyi, Judit Dobos, Anna Sipos, Sándor Boros, Eszter Illyés, Ferenc Baska, László Kékesi, István Szabadkai, Csaba Szántai-Kis, Gÿorgý Kéri, László Őrfi	2015	31
11	Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma Current Cancer Drug Targets ·István Kenessey, M Keszthelyi, Zachary Kramer, Judit Berta, Ammar Adam, Judit Dobos, Michael Mildner, Beáta Flachner, Sándor Cseh, Gábor Barna, Bálint Szokol, László Őrfi, G Kéri, Balázs Döme, Walter Klepetko, József Tı́már, József Tóvári	2010	26
12	Investigation of circulating endothelial progenitor cells and angiogenic and inflammatory cytokines during recovery from an episode of major depression Journal of Affective Disorders ·Péter Döme, Zsuzsa Halmai, Judit Dobos, Judit Lazáry, Xénia Gonda, István Kenessey, Timea Sallai, Zoltán Makkos, Gábor Faludi	2011	25
13	Glucocorticoid Receptor Expression and Antiproliferative Effect of Dexamethasone on Human Melanoma Cells Pathology & Oncology Research ·Judit Dobos, István Kenessey, József Tı́már, Andrea Ladányi	2011	24
14	Recombinant Human Erythropoietin alpha Improves the Efficacy of Radiotherapy of a Human Tumor Xenograft, Affecting Tumor Cells and Microvessels Strahlentherapie und Onkologie ·József Lövey, Bíborka Bereczky, Réka Gilly, István Kenessey, Erzsébet Rásó, Erika Simon, Judit Dobos, Ágnes Vágó, Miklós Kásler, Balázs Döme, József Tı́már, József Tóvári	2008	22
15	Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant/PTEN Wild-Type Melanoma Cells PLoS ONE ·Tamás Garay, István Kenessey, Eszter Molnár, Éva Juhász, Andrea Réti, Viktória László, Anita Rózsás, Judit Dobos, Balázs Döme, Walter Berger, Walter Klepetko, József Tóvári, József Tı́már, Balázs Hegedűs	2015	20
16	Parallel expression of αIIbβ3 and αvβ3 integrins in human melanoma cells upregulates bFGF expression and promotes their angiogenic phenotype International Journal of Cancer ·Balázs Döme, Erzsébet Rásó, Judit Dobos, Lívia S. Mészáros, Norbert Varga, László G. Puskás, László Z. Fehér, Tamár Lörincz, Andrea Ladányi, Mohit Trikha, Kenneth V. Honn, József Tı́már	2005	20
17	Inhibition of epidermal growth factor receptor improves antitumor efficacy of vemurafenib in BRAF-mutant human melanoma in preclinical model Melanoma Research ·István Kenessey, Zsófia Kramer, Lilla István, Mihály Cserepes, Tamás Garay, Balázs Hegedűs, Judit Dobos, József Tı́már, József Tóvári	2018	20
18	Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma Bioorganic & Medicinal Chemistry Letters ·Zsófia Czudor, M. BALOGH, Péter Bánhegyi, Sándor Boros, Nóra Breza, Judit Dobos, Márk Fábián, Zoltán Horváth, Eszter Illyés, Péter Markó, Anna Sipos, Csaba Szántai-Kis, Bálint Szokol, László Őrfi	2018	19
19	Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinases European Journal of Medicinal Chemistry ·Ferenc Baska, Anna Sipos, Zoltán Őrfi, Zoltán Nemes, Judit Dobos, Csaba Szántai-Kis, Eszter Szabó, Gábor Szénási, László Dézsi, Péter Hamar, Mihály Cserepes, József Tóvári, Rita Garamvölgyi, Marcell Krekó, László Őrfi	2019	12
20	Inclusion complexation of the anticancer drug pomalidomide with cyclodextrins: fast dissolution and improved solubility Heliyon ·Zoltán‐István Szabó, G Orban, Enikő Borbás, Dóra Csicsák, Szabina Kádár, Béla Fiser, Máté Dobó, Péter Horváth, Eszter Kiss, Lívia Budai, Judit Dobos, Tamás Pálla, László Őrfi, Gergely Völgyi, Gergő Tóth	2021	12

About Judit Dobos

Judit Dobos is a scholar working on Molecular Biology, Oncology, Hematology, Cancer Research and Organic Chemistry, having authored 33 papers that have together received 989 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Angiogenesis and VEGF in Cancer (5 papers), HER2/EGFR in Cancer Research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Apelin-related biomedical research (3 papers), Cancer-related Molecular Pathways (3 papers), Immunotherapy and Immune Responses (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Biological Psychiatry (42 citations), Oncology (377 citations), Behavioral Neuroscience (39 citations), Cancer Research (155 citations) and Immunology (192 citations). Judit Dobos has collaborated with scholars based in Hungary, Austria and United States. Frequent co-authors include József Tı́már, István Kenessey, József Tóvári, Balázs Döme, Andrea Ladányi, Sándor Paku, Gyula Ostoros, Erzsébet Rásó, Krisztina Bogos and Gábor L. Kovaćs. Their work appears in journals such as Pathology & Oncology Research, Cancer Research, European Journal of Medicinal Chemistry, Journal of Affective Disorders and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact